Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2005
10/25/2005US6958214 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/25/2005US6958212 coupling of a pharmaceutically active compound to a polymer using a conjugate addition reaction, and the cross-linking of the polymer to form a biomaterial, in some embodiments using conjugate addition reactions; controlled release of drug
10/25/2005US6958147 Use of VEGF-C to prevent restenosis
10/23/2005CA2502549A1 Use of an extraction control in a method of extracting nucleic acids
10/20/2005WO2005098448A2 Method and biomarkers for detecting tumor endothelial cell proliferation
10/20/2005WO2005098046A2 Methods for the determination of cell specific biomarkers
10/20/2005WO2005098043A2 Ligand-dependent protein splicing
10/20/2005WO2005098021A1 Detecting targets using nucleic acids having both a variable region and a conserved region
10/20/2005WO2005097998A2 Il-18 specific polypeptides and therapeutic uses thereof
10/20/2005WO2005097992A2 Modified polynucleotides for reducing off-target effects in rna interference
10/20/2005WO2005097832A2 Humanized anti-tgf-beta antibodies
10/20/2005WO2005097818A2 An assay system for screening protease inhibitors
10/20/2005WO2005097817A2 Process and reagents for oligonucleotide synthesis and purification
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097205A2 Dna virus microrna and methods for inhibiting same
10/20/2005WO2005097195A2 Methods of reducing aggregation of il-1ra
10/20/2005WO2005096781A2 Methods and compositions for treating gain-of-function disorders using rna interference
10/20/2005WO2005062867A3 Novel carotenoids ketolases
10/20/2005WO2005040180A3 Antisense modulation of superoxide dismutase 1, soluble (sod-1) expression
10/20/2005WO2005033694A3 Novel antisense oligomers and use thereof
10/20/2005WO2005031005A3 Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
10/20/2005WO2005030139A3 Seneca valley virus based compositions and methods for treating disease
10/20/2005WO2005020794A3 Taxane chemosensitivity prediction test
10/20/2005WO2005010142A8 Plant centromere compositions
10/20/2005WO2004007684A3 Synthetic tag genes
10/20/2005US20050235384 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine
10/20/2005US20050235382 Plant regulatory sequences for selective control of gene expression
10/20/2005US20050235380 Acquired resistance genes in plants
10/20/2005US20050235378 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
10/20/2005US20050235375 Transcription factors of cereals
10/20/2005US20050235371 Noval modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
10/20/2005US20050234221 genetic vectors, host cells and nucleotide sequences that code polypeptides, agonists and antagonists, that preferentially bind to interleukins, used for diagnosis oro prophylaxis of diseases
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050234003 Method of using nucleic acid compositions for muting expression of a gene in animals
10/20/2005US20050234002 Antisense oligomers and methods for inducing immune tolerance and immunosuppression
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233998 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; use in therapeutic, diagnostic, target validation, and genomic discovery
10/20/2005US20050233997 RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
10/20/2005US20050233996 RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA)
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233455 Acyclic linker-containing oligonucleotides and uses thereof
10/20/2005US20050233429 vector and host cell comprising nucleic acid of invention; nucleic acid sequence encoding cyclcooxygenase-1 variant
10/20/2005US20050233418 Cytokine polypeptides
10/20/2005US20050233416 Mutant protein with insertion, deletion, or replacement; lysine production; gene expression
10/20/2005US20050233413 Neuroprotective polypeptides and methods of use
10/20/2005US20050233369 Biosynthetic gene cluster for jerangolids
10/20/2005US20050233368 Canine pancreatic lipase
10/20/2005US20050233360 Nucleic acid probes and methods to detect and/or quantify nucleic acid analytes
10/20/2005US20050233355 Human cDNAs encoding polypeptides having kinase functions
10/20/2005US20050233347 Can be used for the treatment of diabetes or for delaying the onset of diabetes
10/20/2005US20050233344 RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
10/20/2005US20050233343 Composition of matter comprising library of analytes hybridized to nucleic acid array for generating complex formation and signaling domains
10/20/2005US20050233329 Inhibition of gene expression using duplex forming oligonucleotides
10/20/2005US20050233321 Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
10/20/2005US20050233315 Cloned genes encoding reverse transcriptase lacking RNase H activity
10/20/2005US20050233313 Methods and reagents for identifying inhibitors of viral protease activity
10/20/2005US20050233311 Family of picornaviruses
10/20/2005US20050233003 Nanosized particles of salicylic acid wrapped in an amphiphilic polymer of polyacrylic acid, polyacrylamide, polymethacrylamide and polylysine; polymer is modified with urea, nicotinamide or guanidine
10/20/2005US20050232941 Compounds and methods for treatment and diagnosis of chlamydial infection
10/20/2005US20050232940 Recombinant plasmid and a method of controlling the effects of yersinia pestis
10/20/2005US20050232938 Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
10/20/2005US20050232934 Recombinant reverse transcriptases
10/20/2005US20050232926 Expressed in melanoma, breast cancer and hepatocellular carcinoma; fab fragments; fv fragments; competitive binding; for inducing caspase mediated apoptosis; neoplasm diagnosis
10/20/2005US20050232919 Monoclonal antibodies that specifically block biological activity of a tumor antigen
10/20/2005US20050232918 Differentially expressed genes associated with obesity and type 2 diabetes
10/20/2005US20050232914 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof
10/20/2005DE29825175U1 New nucleic acid probes which hybridise to chromosomes - useful for detecting chromosome aberrations and diseases, especially haematopoietic malignancies
10/20/2005CA2590604A1 Microrna encoded by ebv, kshv and hcmv and microrna for targeting the same
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2561741A1 Processes and reagents for oligonucleotide synthesis and purification
10/20/2005CA2561686A1 Humanized anti-tgf-beta antibodies
10/20/2005CA2561338A1 Method and biomarkers for detecting tumor endothelial cell proliferation
10/20/2005CA2561276A1 Irta-5 antibodies and their uses
10/19/2005EP1586642A2 Tumor supressor genes, proteins encoded thereby and use of said genes and proteins
10/19/2005EP1586640A2 Stabilisation of double-stranded nucleic acids using proteins
10/19/2005EP1586636A1 Hydantoinase variants with improved properties and their use for the production of amino acids
10/19/2005EP1585972A2 Methods and compositions for diagnosing and monitoring transplant rejection
10/19/2005EP1585968A2 ISOTHERMAL AMPLIFICATION BASED ASSAY FOR THE DETECTION AND QUANTITATION OF ALPHA-FETOPROTEIN mRNA
10/19/2005EP1585967A2 Methods for detecting nucleic acid sequence variations
10/19/2005EP1585957A2 Magneto-optical bio-discs and systems including related methods
10/19/2005EP1585956A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2005EP1585834A1 Releasable polymer arrays
10/19/2005EP1585832A1 Compositions and methods for polynucleotide detection
10/19/2005EP1585830A2 Photoactivatable two-stage protective groups for the synthesis of biopolymers
10/19/2005EP1585824A2 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
10/19/2005EP1585809A2 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
10/19/2005EP1585760A2 Btl-ii nucleic acids, proteins, and antibodies
10/19/2005EP1585755A1 Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support
10/19/2005EP1585754A2 Alkyl-linked nucleotide compositions
10/19/2005EP1585433A2 Detection methods
10/19/2005EP1585384A2 Precise breeding
10/19/2005EP1492879A4 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
10/19/2005EP1152061B1 Method for screening physiologically active pyrrole imidazole derivative
10/19/2005CN1685058A Peptides with anti-hypertensive properties
10/19/2005CN1684977A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
10/19/2005CN1223607C Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application
10/18/2005US6956032 Dyes derivatized to react with hydroxy and amine groups to covalently attach to antibodies, antigens, peptides, nucleotides, hormones, drugs, or non-biological materials; increased intensity due to increased of dye molecules attached; probes
10/18/2005US6955916 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
10/18/2005US6955915 Solid phase synthesis; photolithography
1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 899